A pivotal role of endothelial-specific NF-kappa;B signaling in the pathogenesis of septic shock and septic vascular dysfunction

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 4031-4038

  Ding, Jianqiang ^a,b   Song, Dongmei ^a,b   Ye, Xiaobing ^a,b   Liu, Shu Fang ^a,b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRATE; NITRITE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD LEVEL; CECUM; CONTROLLED STUDY; HYPOTENSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VASOCONSTRICTION; VASODILATATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM; GENE EXPRESSION; GENETICS; HEMODYNAMICS; METABOLISM; PHYSIOLOGY; VASCULAR DISEASE;

ANIMALS; ENDOTHELIUM; GENE EXPRESSION; HEMODYNAMICS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MICE; MICE, TRANSGENIC; NF-KAPPA B; NITRIC OXIDE SYNTHASE; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR DISEASES;

EID: 70349307058     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900105     Document Type: Article

References (32)

1. Riedemann, N. C., R. F. Guo, and P. A. Ward. 2003. The enigma of sepsis. J. Clin. Invest. 112: 460-467.
2. Liu, S. F., and A. B. Malik. 2006. NF-κB activation as a pathologic mechanism of septic shock and inflammation. Am. J. Physiol. 290: L622-L645.
3. Brown, M. A., and W. K. Jones. 2004. NF-κB action in sepsis: the innate immune system and the heart. Front. Biosci. 9: 1201-1217. (Pubitemid 39060836)
4. Liu, S. F., and P. J. Barnes. 1994. Role of endothelium in the control of pulmonary vascular tone. Endothelium 2: 11-33. (Pubitemid 24269061)
5. Hollenberg, S. M., M. Broussard, L. Osman, and J. E. Parrillo. 2000. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ. Res. 86: 774-778.
6. Hoque, A. M., A. Papapetropoulos, R. C. Venema, J. D. Catravas, and L. C. Fuchs. 1998. Effects of antisense oligonucleotide to iNOS on hemodynamic and vascular changes induced by LPS. Am. J. Physiol. 275: H1078-H1083.
7. Boyle, W. A., III, L. S. Parvathaneni, V. Bourlier, C. Sauter, V. E. Laubach, and J. P. Cobb. 2000. iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ. Res. 87: E18-E24.
8. Anderson, H. D., D. Rahmutula, and D. G. Gardner. 2004. Tumor necrosis factor-α inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J. Biol. Chem. 279: 963-969.
9. Colasanti, M., T. Persichini, E. Cavalieri, C. Fabrizi, S. Mariotto, M. Menegazzi, G. M. Lauro, and H. Suzuki. 1999. Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-γ-induced tyrosine phosphorylation. J. Biol. Chem. 274: 9915-9917.
10. Faraci, F. M., C. D. Sigmund, E. G. Shesely, N. Maeda, and D. D. Heistad. 1998. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am. J. Physiol. 274: H564-H570.
11. Lund, D. D., F. M. Faraci, F. J. Miller, Jr., and D. D. Heistad. 2000. Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rabbits. Circulation 101: 1027-1033. (Pubitemid 30131706)
12. Liu, S. F., X. Ye, and A. B. Malik. 1999. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression proinflammatory genes. Circulation 100: 1330-1337.
13. Liu, S. F., X. Ye, and A. B. Malik. 1997. In vivo inhibition of NF-κB activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159: 3976-3983.
14. Sheehan, M. H., R. Wong, P. W. Hake, V. Malhotra, M. O'Connor, and B. Zingarelli. 2002. Parthenolide, an inhibitor of the nuclear factor-κB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol. Pharmacol. 61: 953-963.
15. Altavilla, D., G. Squadrito, L. Minutoli, B. Deodato, A. Bova, A. Sardella, P. Seminara, M. Passaniti, G. Urna, S. F. Venuti, et al. 2002. Inhibition of nuclear factor-κB activation by IRFI 042 protects against endotoxin-induced shock. Cardiovasc. Res. 54: 684-693.
16. Haudek, S. B., E. Spencer, D. D. Bryant, D. J. White, D. Maass, J. W. Horton, Z. J. Chen, and B. P. Giroir. 2001. Overexpression of cardiac I-κBα prevents endotoxin-induced myocardial dysfunction. Am. J. Physiol. 280: H962-H968.
17. Ye, X., D. Ding, Z. Zhou, G. Chen, and S. F. Liu. 2008. Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in murine models of sepsis. J. Exp. Med. 205: 1303-1315. (Pubitemid 351831488)
18. Zaph, C., A. C. Troy, B. C. Taylor, L. D. Berman-Booty, K. J. Guild, Y. Du, E. A. Yost, A. D. Gruber, M. J. May, F. R. Greten, et al. 2007. Epithelial-cellintrinsic IKK-β expression regulates intestinal immune homeostasis. Nature 446: 552-556.
19. Cheng, D.-S., W. Han, S. M. Chen, T. P. Sherrill, M. Chont, G.-Y. Park, J. R. Sheller, W. Polosukhin, J. W. Christman, F. E. Yull, and T. S. Blackwell. 2007. Airway epithelium controls lung inflammation and injury through the NF-κB pathway. J. Immunol. 178: 6504-6513.
20. Lerman, A., and J. C. Burnett, Jr. 1992. Intact and altered endothelium in regulation of vasomotion. Circulation 86(Suppl. 6): III12-III19.
21. Aird, W. C. 2003. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 15: 3765-3777.
22. Chan, E. L., S. B. Haudek, B. P. Giroir, and J. T. Murphy. 2001. Human coronary endothelial cell activation by endotoxin is characterized by NF-κB activation and TNF-α synthesis. Shock 16: 349-354.
23. Faure, E., L. Thomas, H. Xu, A. Medvedev, O. Equils, and M. Arditi. 2001. Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J. Immunol. 166: 2018-2024. (Pubitemid 32114690)
24. Zhang, F. X., C. J. Kirschning, R. Mancinelli, X. P. Xu, Y. Jin, E. Faure, A. Mantovani, M. Rothe, M. Muzio, and M. Arditi. 1999. Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274: 7611-7614.
25. Hart, C. Y., J. C. Burnett, Jr., and M. M. Redfield. 2001. Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am. J. Physiol. 281: H1938-H1945.
26. Berthiaume, N., F. Hess, A. Chen, D. Regoli, and P. D'Orléans- Juste. 1997. Pharmacology of kinins in the arterial and venous mesenteric bed of normal and B2 knockout transgenic mice. Eur. J. Pharmacol. 333: 55-61. (Pubitemid 27380450)
27. Didion, S. P., D. A. Kinzenbaw, P. E. Fegan, L. A. Didion, and F. M. Faraci. 2004. Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction. Stroke 35: 1963-1967.
28. Henke, N., R. Schmidt-Ullrich, R. Dechend, J. K. Park, F. Qadri, M. Wellner, M. Obst, V. Gross, R. Dietz, F. C. Luft, et al. 2007. Vascular endothelial cell-specific NF-κB suppression attenuates hypertension-induced renal damage. Circ. Res. 101: 268-276.
29. Gareus, R., E. Kotsaki, S. Xanthoulea, I. van der Made, M. J. Gijbels, R. Kardakaris, A. Polykratis, G. Kollias, M. P. de Winter, and M. Pasparakis. 2008. Endothelial cell-specific NF-κB inhibition protects mice from atherosclerosis. Cell Metab. 8: 372-383.
30. Kisseleva, T., S. Li, M. Vorontchikhina, N. Feirt, J. Kitajewski, and C. Schindler. 2006. NF-κB regulation of endothelial cell function during LPS-induced toxemia and cancer. J. Clin. Invest. 116: 2955-2963.
31. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80: 321-330.
32. Lavon, I., I. Goldberg, S. Amitm, L. Landsman, S. Jung, B. Z. Tsuberi, I. Barshack, J. Kopolovic, E. Galun, H. Bujard, and Y. Ben-Neriah. 2000. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nat. Med. 6: 573-577.